Yorktown Management & Research Company’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,300
Closed -$273K 279
2026
Q1
$273K Buy
+1,300
New +$327K 0.23% 171
2023
Q4
Sell
-2,150
Closed -$343K 221
2023
Q3
$343K Hold
2,150
0.39% 111
2023
Q2
$620K Hold
2,150
0.67% 42
2023
Q1
$686K Hold
2,150
0.74% 25
2022
Q4
$633K Hold
2,150
0.77% 24
2022
Q3
$493K Hold
2,150
0.64% 49
2022
Q2
$469K Hold
2,150
0.6% 55
2022
Q1
$573K Hold
2,150
0.49% 70
2021
Q4
$572K Hold
2,150
0.39% 100
2021
Q3
$611K Hold
2,150
0.46% 63
2021
Q2
$590K Buy
2,150
+650
+43% +$177K 0.46% 58
2021
Q1
$391K Hold
1,500
0.32% 111
2020
Q4
$383K Hold
1,500
0.34% 143
2020
Q3
$355K Hold
1,500
0.33% 144
2020
Q2
$291K Hold
1,500
0.26% 201
2020
Q1
$249K Buy
+1,500
New +$274K 0.25% 165
2014
Q3
Sell
-5,200
Closed -$206K 489
2014
Q2
$206K Hold
5,200
0.04% 437
2014
Q1
$247K Buy
+5,200
New +$230K 0.05% 320

Other funds holding PODD

Yorktown Management & Research Company's PODD Position: Q2 2026 in Review

Yorktown Management & Research Company sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,300 shares — an estimated $273K sold.

Yorktown Management & Research Company first reported a position in PODD in Q1 2014 and held it in 18 quarters. The position peaked at $686K in Q1 2023. 338 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Yorktown Management & Research Company reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Yorktown Management & Research Company sold 1,300 Insulet shares in Q2 2026, an estimated $273K.
  • Yorktown Management & Research Company first reported a position in Insulet in Q1 2014 and held it in 18 quarters.
  • Yorktown Management & Research Company's Insulet position peaked at $686K in Q1 2023.
  • 338 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.